osimertinib
astrazeneca
[]
 telling by the near merging of the dfs curves after osi discont., pts in exp arm will generate all of the above costs too later on. but one never gets the money (and other tox) back for those who were cured post-surgery (and chemo) and never needed osi in the first place.